Literature DB >> 35779057

Descemet membrane endothelial keratoplasty in complex eyes.

Aazim Siddiqui1, Winston D Chamberlain.   

Abstract

PURPOSE OF REVIEW: To review the current literature on Descemet membrane endothelial keratoplasty (DMEK) in complex eyes. RECENT
FINDINGS: DMEK surgery has become a standardized procedure in Fuchs endothelial dystrophy and simple bullous keratopathy. But eyes with more complex disease present unique intraoperative and postoperative challenges to the DMEK surgeon. Poor visualization during surgery, complex anterior segment anatomy, altered anterior chamber dynamics, glaucoma shunts, and congenital or iatrogenic missing or altered iris and lens make DMEK surgery extremely difficult to accomplish.
SUMMARY: DMEK is feasible in complex eyes, including advanced bullous keratopathy, eyes with history of glaucoma or vitreoretinal surgery, previous penetrating keratoplasty, uveitis, pediatric, and congenital anterior segment disorders. The tools and methods reported in the literature to accomplish DMEK in complex eyes vary widely with no particular consensus or standardization of techniques. The outcomes noted for some of these conditions demonstrate the difficulty of the surgery and the uncertainty of long-term graft survival in complex eyes. Both surgical standardization and randomized prospective data will better help elucidate DMEK's role in the corneal rehabilitation of complex eyes.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35779057      PMCID: PMC9261113          DOI: 10.1097/ICU.0000000000000865

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   4.299


  52 in total

1.  Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty.

Authors:  Arundhati Anshu; Marianne O Price; Francis W Price
Journal:  Ophthalmology       Date:  2012-01-03       Impact factor: 12.079

2.  Standardized DMEK Technique: Reducing Complications Using Prestripped Tissue, Novel Glass Injector, and Sulfur Hexafluoride (SF6) Gas.

Authors:  Mark A Terry; Michael D Straiko; Peter B Veldman; Julia C Talajic; Cor VanZyl; Christopher S Sales; Zachary M Mayko
Journal:  Cornea       Date:  2015-08       Impact factor: 2.651

3.  Comparison of Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty in the Treatment of Failed Penetrating Keratoplasty.

Authors:  Adi Einan-Lifshitz; Zale Mednick; Avner Belkin; Nir Sorkin; Sara Alshaker; Tanguy Boutin; Clara C Chan; David S Rootman
Journal:  Cornea       Date:  2019-09       Impact factor: 2.651

4.  Pediatric Descemet Membrane Endothelial Keratoplasty.

Authors:  Bhaskar Srinivasan; Manokamna Agarwal; Geetha Iyer; Shweta Agarwal; Prema Padmanabhan
Journal:  Am J Ophthalmol       Date:  2021-02-12       Impact factor: 5.258

5.  C-Press Technique to Facilitate Descemet Membrane Endothelial Keratoplasty Surgery in Vitrectomized Patients: A Case Series.

Authors:  Alain Saad; Shady T Awwad; Nasrine Anais El Salloukh; Christophe Panthier; Ziad Bashur; Damien Gatinel
Journal:  Cornea       Date:  2019-09       Impact factor: 2.651

Review 6.  Pediatric endothelial keratoplasty: a systematic review and individual participant data meta-analysis.

Authors:  Masomeh Mohebbi; Mohammad Mehrpour; Amin Dehghani Sanij; Nader Mohammadi; Masoud Mirghorbani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-28       Impact factor: 3.117

7.  Double-Bubble Technique in Descemet Membrane Endothelial Keratoplasty for Vitrectomized Eyes: A Case Series.

Authors:  Takahiko Hayashi; Akira Kobayashi
Journal:  Cornea       Date:  2018-09       Impact factor: 2.651

8.  Outcomes of Pseudophakic, Phakic, and Triple DMEK.

Authors:  Isabella Moshiri; Damian Karimi-Golkar; Silvia Schrittenlocher; Claus Cursiefen; Björn Bachmann
Journal:  Cornea       Date:  2021-10-01       Impact factor: 2.651

9.  Successful pediatric DMEK facilitated by intracameral tissue plasminogen activator to mitigate anterior chamber fibrin reaction.

Authors:  Tanner J Ferguson; Elias I Traboulsi; Jeffrey M Goshe
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.